Okay, let's tackle this question. The patient has acute bronchial asthma after treatment for glaucoma. The key here is to figure out which drug used for glaucoma can cause bronchospasm or worsen asthma.

First, I remember that glaucoma treatments include beta-blockers like timolol. Beta-blockers are contraindicated in asthma because they can cause bronchoconstriction by blocking beta-2 receptors in the lungs. Acute asthma exacerbation is a known side effect.

Wait, other glaucoma medications like prostaglandin analogs (e.g., latanoprost) or alpha agonists (e.g., brimonidine) don't typically cause this. So the likely culprit is a non-selective beta-blocker. Timolol is a non-selective beta-blocker, so if the patient was given that, it could trigger asthma symptoms.

Looking at the options, the correct answer would be the beta-blocker. The other options might be other types of drugs used for glaucoma. For example, pilocarpine is a cholinergic agonist, which can cause other side effects but not bronchospasm. So the answer should be the beta-blocker used in glaucoma treatment, like timolol.

So the core concept here is the interaction between beta-blockers and asthma. The correct answer is the beta-blocker, and the others are incorrect because they don't have that mechanism. The clinical pearl is to avoid non-selective beta-blockers in patients with asthma.

**Core Concept** Acute bronchial asthma exacerbation can occur due to **non-selective beta-blockers**, which are used in glaucoma treatment. These drugs block **beta-2 adrenergic receptors** in bronchial smooth muscles, causing bronchoconstriction. Timolol, a non-selective beta-blocker, is a classic example.

**Why the Correct Answer is Right** The patient developed bronchial asthma after glaucoma treatment, pointing to **timolol** as the causative agent. Timolol inhibits beta-1 and beta-2 receptors. While beta-1 blockade lowers intraocular pressure, beta-2 blockade in the lungs leads to bronchoconstriction, worsening asthma. This is a well-documented contraindication of non-selective beta-blockers in asthmatic patients.

**Why Each Wrong Option is Incorrect**
**Option A:** *Pilocarpine* is a cholinergic agonist used in glaucoma; it does not affect bronchial smooth muscle.
**Option B:** *Latanoprost* is a prostaglandin analog that increases aqueous humor outflow. It has no bronchoconstrictive effects.
**Option C:** *Brimonidine* is an alpha-2 agonist used for glaucoma. Its primary side effects are ocular, not respiratory.

**Clinical Pearl** Always **avoid non-selective beta-blockers (e.g., timolol)** in patients with a history of asthma or chronic obstructive pulmonary disease (COPD). Use **selective beta-1 blockers (e.g., metipranolol)** for glaucoma in such cases to minimize pulmonary side effects.

**Correct Answer: C. Timolol**

✓ Correct Answer: A. Timolol